METIPRANOLOL Drug Patent Profile
✉ Email this page to a colleague
When do Metipranolol patents expire, and when can generic versions of Metipranolol launch?
Metipranolol is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in METIPRANOLOL is metipranolol hydrochloride. There are two drug master file entries for this compound. Additional details are available on the metipranolol hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METIPRANOLOL?
- What are the global sales for METIPRANOLOL?
- What is Average Wholesale Price for METIPRANOLOL?
Summary for METIPRANOLOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 38 |
Patent Applications: | 4,028 |
DailyMed Link: | METIPRANOLOL at DailyMed |
US Patents and Regulatory Information for METIPRANOLOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sandoz | METIPRANOLOL | metipranolol hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 075720-001 | Aug 6, 2001 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |